Vitasora Health Limited
VHLUF
$0.01
-$0.05-91.39%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 148.49% | 140.88% | 578.53% | 565.82% | 533.33% |
| Total Other Revenue | -9.74% | -12.50% | -- | -- | 5.12% |
| Total Revenue | 85.89% | 80.17% | 578.53% | 565.82% | 111.74% |
| Cost of Revenue | -74.72% | -75.42% | -87,600.00% | -85,800.00% | 7,507.69% |
| Gross Profit | 125.11% | 118.23% | 664.51% | 650.10% | 71.17% |
| SG&A Expenses | 53.54% | 48.86% | 101.77% | 97.98% | 28.58% |
| Depreciation & Amortization | 2,086.73% | 2,036.00% | 213.25% | 212.05% | -66.32% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.02% | 50.29% | 97.31% | 93.61% | 34.52% |
| Operating Income | -41.93% | -37.58% | -59.49% | -56.50% | -16.48% |
| Income Before Tax | -41.93% | -37.58% | -59.42% | -56.43% | -14.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.93% | -37.58% | -59.45% | -56.46% | -14.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.93% | -37.58% | -59.45% | -56.46% | -14.17% |
| EBIT | -41.93% | -37.58% | -59.49% | -56.50% | -16.48% |
| EBITDA | -42.30% | -37.96% | -60.07% | -57.84% | -18.92% |
| EPS Basic | 0.00% | 0.00% | -18.18% | -18.18% | 9.09% |
| Normalized Basic EPS | 0.00% | 0.00% | -14.29% | -14.29% | 14.29% |
| EPS Diluted | 0.00% | 0.00% | -8.33% | -8.33% | 9.09% |
| Normalized Diluted EPS | 0.00% | 0.00% | -14.29% | -14.29% | 14.29% |
| Average Basic Shares Outstanding | 43.49% | 43.49% | 39.76% | 39.76% | 33.92% |
| Average Diluted Shares Outstanding | 43.49% | 43.49% | 39.76% | 39.76% | 33.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |